Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-22T07:14:05.690Z Has data issue: false hasContentIssue false

Special Populations

Published online by Cambridge University Press:  07 November 2014

Abstract

Obsessive-compulsive disorder (OCD) is a formidable public health problem, rated by the World Health Organization as one of the top 20 most disabling diseases.The shame and secrecy associated with OCD, as well as the lack of recognition of its characteristic symptoms, particularly by primary care physicians, hinders appropriate diagnosis and treatment. Most adults with OCD report a late adolescent or early adulthood onset, yet OCD can occur throughout the life span. Pre-school children have been known to develop the disorder, as have elderly persons. OCD can cause considerable distress and disability; for example, children may fall behind in their education, and adults can become housebound. Comorbid psychiatric disorders have become an area of intense interest. Comorbid depression for example, is frequently the symptom that leads the individual to seek treatment. Patients with schizophrenia frequently develop obsessions and compulsions, and these symptoms are associated with a poorer outcome. The role of second-generation antipsychotics merits further study in the treatment of this subset of patients. An important step toward delineating specific subgroups within the OCD-schizophrenia axis may be the use of endophenotypic markers. Unfortunately, many patients with OCD will have a less than optimal treatment response. Poor treatment response is associated with serious social disability, but there are few clues to guide clinicians in predicting treatment response in patients with OCD, in terms of specific demographic variables, clinical symptoms, or the presence of comorbid psychiatric disorders.

Type
Supplements
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC American Psychiatric Association; 1994.Google Scholar
2. Flament, MF, Geller, D, Irak, M, Blier, P. Specificities of treatment in pediatric obsessive-compulsive disorder. CNS Spectr. 2007;12(2 suppl 3):4358.CrossRefGoogle Scholar
3. International Classification of Diseases and Related Health Problems. 10th rev. World Health Organization; 2003.Google Scholar
4. Weiss, AP, Jenike, MA. Late-onset obsessive-compulsive disorder: A case series. J Neumpsychiatry Clin Neurosci. 2000;12:265268.CrossRefGoogle ScholarPubMed
5. Insel, TR, Akiskal, HS. Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis. Am J Psychiatry. 1986;143(12):15271533.Google ScholarPubMed
6. Eisen, JL, Rasmussen, SA, Phillips, KA, et al. Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry. 2001;42(6):494497.CrossRefGoogle ScholarPubMed
7. Ravi-Kishore, V, Samar, R, Janardhan-Reddy, YC, Chandrasekhar, CR, Thennarasu, K. Clinical characteristics and treatment response in poor and good insight obsessive-compulsive disorder. Eur Psychiatry. 2004;19:202208.CrossRefGoogle ScholarPubMed
8. Mansueto, CS, Keuler, DJ. Tic or compulsion?: It's tourettic OCD. Behav Modif. 2005;29:784799.CrossRefGoogle ScholarPubMed
9. Pauls, DL, Towbin, KE, Leckman, JF, Zahner, GE, Cohen, DJ). Gilles de la Tourette's syndrome and obsessive-compulsive disorder: Evidence supporting a genetic relationship. Arch Gen Psychiatry. 1986:43:11801182.CrossRefGoogle ScholarPubMed
10. McDougle, CJ, Goodman, WK, Leckman, JF, Lee, NC, Heninger, GR, Price, LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994:51:302308.CrossRefGoogle ScholarPubMed
11. McDougle, CJ, Epperson, CN, Pelton, GH, Wasylink, S, Price, LH. A double-blind, place-bo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2000:57:794801.CrossRefGoogle Scholar
12. Chen, Y-W, Dilsaver, SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995:59:5764.CrossRefGoogle ScholarPubMed
13. Kruger, S, Cooke, RG, Hasey, GM, et al. Comorbidity of obsessive-compulsive disorder in bipolar disorder. J Affect Disord. 1995:34:117120.CrossRefGoogle ScholarPubMed
14. Vieta, E, Bernardo, M, Vallejo, J. Clomipramine induced mania in obsessive-compulsive disorder. Hum Psychopharmacol. 1991:6:7273.Google Scholar
15. Montgomery, S, Zohar, J. Obsessive Compulsive Disorder. Martin Dunitz: London; 1999.Google Scholar
16. Van Ameringen, M, Mancini, C, Patterson, B, Bennett, M. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: A retrospective, open-label case series. Depress Anxiety. 2006;23(1):15.CrossRefGoogle ScholarPubMed
17. Daly, KA, Fatemi, SH. Lamotrogine and impulse behavior. Can J Psychiatry. 1999;44(4):395396.Google Scholar
18. Riggs, DS. Treatment of concurrent PTSD and OCD: A commentary on the case of Howard. Cognitive and Behavioral Practice. 2000:7:130132.CrossRefGoogle Scholar
19. De-Silva, Marks M. Traumatic experiences, post-traumatic stress disorder and obsessive-compulsive disorder. Int Rev Psychiatry. 2001:13:172180.CrossRefGoogle Scholar
20. Jenike, MA. A 45-year old woman with obsessive-compulsive disorder. JAMA. 2001:285:21212128.CrossRefGoogle ScholarPubMed
21. Dinn, WM, Harris, CL, Raynard, RC. Posttraumatic obsessive-compulsive disorder: A three-factor model. Psychiatry. 1999:62:313324.CrossRefGoogle ScholarPubMed
22. Pitman, RK. Posttraumatic obsessive-compulsive disorder: A case study. Compr Psychiatry. 1993:34:102107.CrossRefGoogle ScholarPubMed
23. Maina, G, Umberto, A, Bogetto, F, Vaschetto, P, Ravizza, L. Recent life events and obsessive compulsive disorder: The role of pregnancy/delivery. Psychiatry Res. 1999:4958.Google Scholar
24. Janet, P, Raymond, F. Les Obsessions et la Psychastheniae [Obsessions and psychasthenie]. New York, NY: Arno; 1976.Google Scholar
25. Sasson, Y, Dekel, S, Nacasch, N, Chopra, M, Zinger, Y, Amital, D, Zohar, J. Posttraumatic obsessive-compulsive disorder: A case series. Psychiatry Res. 2005:135:145152.CrossRefGoogle ScholarPubMed
26. Gershuny, BS, Baer, L, Jenike, MA, Minichiello, WE, Wilhelm, S. Comorbid posttraumatic stress disorder: Impact on treatment outcome for obsessive compulsive disorder. Am J Psychiatry. 2002;159:852854.CrossRefGoogle ScholarPubMed
27. Freeman, JB, Leonard, HL. Sexual obsessions in obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:141142.CrossRefGoogle ScholarPubMed
28. Jordan, BK, Schlenger, WE, Hough, R, et al. Lifetime and curent prevalence of specific psychiatric disorders among Vietnam veterans and controls. Arch Gen Psychiatry. 1991:48:207215.CrossRefGoogle Scholar
29. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1990.Google Scholar
30. Fabisch, K, Fabisch, H, Langs, G, Huber, HP, Zapotoczky, HG. Incidence of obsessive-compulsive phenomena in the course of acute schizophrenia and schizoaffective disorder. Eur Psychiatry. 2001:16:336341.CrossRefGoogle ScholarPubMed
31. Nechmad, A, Ratzoni, G, Poyurovsky, M, et al. Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry. 2003:160:10021004.CrossRefGoogle ScholarPubMed
32. Fenton, WS, McGlashan, TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986:143:437441.Google ScholarPubMed
33. Berman, I, Kalinowski, A, Berman, SM, Lengua, J, Green, AI. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry. 1995:36:610.CrossRefGoogle ScholarPubMed
34. Berman, I, Merson, A, Viegner, B, Losonczy, MF, Pappas, D, Green, AI. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998;186:150156.CrossRefGoogle ScholarPubMed
35. Hwang, MY, Morgan, JE, Losconzcy, MF. Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci. 2000:12:9194.CrossRefGoogle ScholarPubMed
36. Lysaker, PH, Marks, KA, Picone, JB, Rollins, AL, Fastenau, PS, Bond, GR. Obsessive and compulsive symptoms in schizophrenia: clinical and neurocognitive correlates. J Nerv Ment Dis. 2000:188:7883.CrossRefGoogle ScholarPubMed
37. Zohar, J, Kaplan, Z, Benjamin, J. Clomipramine treatment of obsessive-compulsive symptomatology in schizophrenic patients. J Clin Psychiatry. 1993:54:358388.Google ScholarPubMed
38. Poyurovsky, M, Isakov, V, Hromnikov, S, et al. Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol. 1999;14:95100.CrossRefGoogle ScholarPubMed
39. Gentile, S. The role of estrogen therapy in postpartum psychiatric disorders: an update CNS Spectr. 2005:10:944952.CrossRefGoogle ScholarPubMed
40. Zonana, J, Gorman, JM. The neurobiology of postpartum depression. CNS Spectr. 2005:10:792–799, 805.CrossRefGoogle ScholarPubMed
41. Battle, CL, Zlotnick, C, Miller, IW, Pearlstein, T, Howard, M. Clinical characteristics of perinatal psychiatric patients: a chart review study. J Nerv Ment Dis. 2006:194:369377.CrossRefGoogle ScholarPubMed
42. Iranfar, S, Shaken, J, Ranjbar, M, NazhadJafar, P, Razaie, M. Is unintended pregnancy a risk factor for depression in Iranian women? East Mediterr Health J. 2005:11:618624.Google ScholarPubMed
43. Enns, GM, O'Brien, WE, Kobayashi, K, Shinzawa, H, Pellegrino, JE. Postpartum “psychosis” in mild argininosuccinate synthetase deficiency. Obstet Gynecol. 2005:105:12441246.CrossRefGoogle ScholarPubMed
44. Nager, A, Johansson, LM, Sundquist, K. Are sociodemographic factors and year of delivery associated with hospital admission for postpartum psychosis? A study of 500,000 first-time mothers. Acta Psychiatr Scand. 2005:112:4753.CrossRefGoogle ScholarPubMed
45. Nager, A, Johansson, LM, Sundquist, K. Neighborhood socioeconomic environment and risk of postpartum psychosis. Arch Womens Ment Health. 2006:9:8186.CrossRefGoogle ScholarPubMed
46. Labad, J, Menchon, JM, Alonso, P, Segalas, C, Jimenez, S, Vallejo, J. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry. 2005:66:428435.CrossRefGoogle ScholarPubMed
47. Geller, PA, Klier, CM, Neugebauer, R. Anxiety disorders following miscarriage. J Clin Psychiatry. 2001:62:432438.CrossRefGoogle ScholarPubMed
48. Vulink, NC, Denys, D, Bus, L, Westenberg, HG. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2006:21(3):171175.CrossRefGoogle ScholarPubMed
49. Neziroglu, F, Anemone, R, Yaryura-Tobias, J. Onset of obsessive compulsive disorder in pregnancy. Am J Psychiatry. 1992:149:947950.Google ScholarPubMed
50. McEwen, . Estrogen actions throughout the brain. Recent Prog Horm Res. 2002:57:357–84.CrossRefGoogle ScholarPubMed
51. McDougle, CJ, Barr, LC, Goodman, WK, Price, LH. Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 1999:24:124.CrossRefGoogle ScholarPubMed
52. Shear, MK, Mammen, O. Anxiety disorders in pregnant and postpartum women. Psychopharmacol Bull. 1995;31(4):693703.Google ScholarPubMed
53. Abramowitz, JS, Schwartz, SA, Moore, KM, Luenzmann, KR. Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. J Anxiety Disord. 2003:17:461478.CrossRefGoogle ScholarPubMed
54. Sichel, DA, Cohen, LS, Rosenbaum, JF, Driscoll, J. Postpartum onset of obsessive-compulsive disorder. Psychosomatics. 1993:34:277279.CrossRefGoogle ScholarPubMed
55. Sichel, DA, Cohen, LS, Dimmock, JA, Rosenbaum, JF. Postpartum obsessive compulsive disorder: a case series. J Clin Psychiatry. 1993:54:156159.Google ScholarPubMed
56. Wisner, KL, Peindl, KS, Gigliotti, T, Hanusa, BH. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry. 1999:60:176180.CrossRefGoogle ScholarPubMed
57. Maina, G, Umberto, A, Bogetto, F, Vashetto, P, Ravizza, L. Recent life events and obsessive compulsive disorder: the role of pregnancy/delivery. Psychiatr Res. 1999:89:4958.CrossRefGoogle ScholarPubMed
58. Labad, J, Menchon, JM, Alonso, P, Segalas, C, Jimenez, S, Vallejo, J. Female reproductive cycle and obsessive compulsive disorder. J Clin Psychiatry. 2005:66:428435.CrossRefGoogle ScholarPubMed
59. Abramowitz, J, Moore, K, Carmin, C, Wiegartz, PS, Purdon, C. Acute onset of obsessive-compulsive disorder in males following childbirth. Psychosomatics. 2001:42(5):429431.CrossRefGoogle ScholarPubMed
60. Brandes, M, Soares, CN, Cohen, LS. Postpartum onset obsessive-compulsive disorder: diagnosis and management. Arch Womens Ment Health. 2004;7(2):99110.CrossRefGoogle ScholarPubMed
61. McDonough, M, Kennedy, N. Pharmacological management of obsessive-compulsive disorder: a review for clinicians. Harv Rev Psychiatry. 2002;10:127137.CrossRefGoogle ScholarPubMed
62. Perionatology.com: Drugs in pregnancy and breastfeeding. Available at: http://www.perinatology.com/exposures/druglist.htm. Accessed January 26, 2007.Google Scholar
63. Chambers, CD, Hernandez-Diaz, S, Van Marter, LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006:354(6):579587.CrossRefGoogle ScholarPubMed
64. Diav-Citrin, O, Ornoy, A. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology. 2002:65(1):3844.CrossRefGoogle ScholarPubMed
65. Hendrick, V, Smith, LM, Suri, R, Hwang, S, Haynes, D, Altshuler, L. Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol. 2003:188:812815.CrossRefGoogle ScholarPubMed
66. Vaswani, M, Linda, FK, Ramesh, S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003:27(1):85102.CrossRefGoogle ScholarPubMed
67. Kulin, NA, Pastuszak, A, Sage, SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA. 1998:279:609610.CrossRefGoogle ScholarPubMed
68. Hemels, ME, Einarson, A, Koren, G, Lanctot, KL, Einarson, TR. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother. 2005:39:803809.CrossRefGoogle ScholarPubMed
69. Sanz, EJ, De-las-Cuevas, C, Kiuru, A, Bate, A, Edwards, R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005:365(9458):482487.Google Scholar
70. Cuzzell, JZ. Paroxetine may increase risk for congenital malformations. Dermatology Nursing. 2006:18(1):68.Google ScholarPubMed
71. Gupta, S, Masand, PS, Rangwani, S. Selective serotonin reuptake inhibitors in pregnancy and lactation. Obstet Gynecol Surv. 1998:53(12):733736.CrossRefGoogle ScholarPubMed
72. Stowe, ZN, Hostetter, AL, Owens, MJ, et al. The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry. 2003:64:7380.CrossRefGoogle ScholarPubMed
73. Whitby, DH, Smith, KM. The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding. Pharmacotherapy. 2005:25(3):411425.CrossRefGoogle ScholarPubMed
74. Franssen, EJ, Meijs, V, Ettaher, F, Valerio, PG, Keessen, M, Lameijer, W. Citalopram serum and milk levels in mother and infant during lactation. Ther Drug Monit. 2006:28:24.CrossRefGoogle ScholarPubMed
75. Skoog, G, Skoog, I. A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1999:56:121127.CrossRefGoogle ScholarPubMed
76. Roth, RM, Milovan, D, Baribeau, J, O'Connor, K. Neuropsychological functioning in early- and late-onset obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 2005;17:208213.CrossRefGoogle ScholarPubMed
77. Mataix-Cols, D, Baer, L, Rauch, SL, Jenike, MA. Relation of factor-analyzed symptom dimensions of obsessive-compulsive disorder to personality disorders. Acta Psychiatr Scand. 2000;102:199202.CrossRefGoogle ScholarPubMed
78. Black, DW, Monahan, P, Blum, N, Gabel, J, Clancy, G, Baker, P. Hoarding and treatment response in 38 non-depressed subjects with obsessive-compulsive disorder. J Clin Psychiatry. 1998:59:420425.CrossRefGoogle Scholar
79. Saxena, S, Maidment, KM, Vapnik, T, et al. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry. 2002:63(1):2127.CrossRefGoogle ScholarPubMed
80. Rufer, M, Fricke, S, Moritz, S, Kloss, M, Hand, I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand. 2006;113:440446.CrossRefGoogle ScholarPubMed
81. Lochner, C, Kinnear, CJ, Hemmings, SM, et al. Hoarding in obsessive-compulsive disorder: clinical and genetic correlates. J Clin Psychiatry. 2005:66:11551160.CrossRefGoogle ScholarPubMed
82. Fontenelle, LF, Mandlowicz, MV, Soares, ID, Versiani, M. Patients with obsessive-compulsive disorder and hoarding symptoms: A distinctive clinical subtype? Compr Psychiatry. 2004;45(5):375383.CrossRefGoogle ScholarPubMed
83. Wu, KD, Watson, D. Hoarding and its relation to obsessive-compulsive disorder. Behav Res Ther. 2005:43:897921.CrossRefGoogle ScholarPubMed
84. Grisham, JR, Brown, TA, Liverant, GI, Campbell-Sills, L. The distinctiveness of compulsive hoarding from obsessive-compulsive disorder. J Anxiety Disord. 2005;19:767779.CrossRefGoogle ScholarPubMed
85. Lasalle-Ricci, VH, Arnkoff, DB, Glass, CR, Crawley, SA, Ronquillo, JG, Murphy, DL. The hoarding dimension of OCD: Psychological comorbidity and the five-factor personality model. Behav Res Ther. 2006:44(10):15031512.CrossRefGoogle ScholarPubMed
86. Samuels, J, Bienvenu, OJ 3rd, Riddle, MA, et al. Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther. 2002:40:517528.CrossRefGoogle ScholarPubMed